Chia‐Chi Lin
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
Papers in
- Oncology 59
- Cancer Immunotherapy and Biomarkers 23
- Lung Cancer Research Studies 16
- Colorectal Cancer Treatments and Studies 13
-
- Lung Cancer Treatments and Mutations 37
- Co-authors
- James Chih‐Hsin Yang (28 shared papers)Jih‐Hsiang Lee (15 shared papers)Bin-Chi Liao (12 shared papers)Chih‐Hung Hsu (22 shared papers)Jin‐Yuan Shih (9 shared papers)Ann‐Lii Cheng (15 shared papers)Chao‐Chi Ho (8 shared papers)Chong‐Jen Yu (9 shared papers)
- Journals
- Journal of Clinical Oncology (27 papers)Cancer Research (10 papers)Journal of Thoracic Oncology (6 papers)Investigational New Drugs (4 papers)Molecular Cancer Therapeutics (4 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Chia‐Chi Lin
113 papers receiving 2.3k citations
Chia‐Chi Lin's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 968
- Pulmonary and Respiratory Medicine 1.0k
- Cancer Research 236
- Immunology 238
- Hepatology 65
Countries citing papers authored by Chia‐Chi Lin
This map shows the geographic impact of Chia‐Chi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Chi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Chi Lin more than expected).
Fields of papers citing papers by Chia‐Chi Lin
This network shows the impact of papers produced by Chia‐Chi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Chi Lin. The network helps show where Chia‐Chi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chia‐Chi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial Hit paper breakdown → | 2019 | 254 |
| 2 | 2015 | 141 | |
| 3 | 2017 | 117 | |
| 4 | 2006 | 108 | |
| 5 | 2019 | 66 | |
| 6 | 2020 | 65 | |
| 7 | 2021 | 55 | |
| 8 | 2011 | 53 | |
| 9 | 2019 | 52 | |
| 10 | 2021 | 45 | |
| 11 | 2013 | 45 | |
| 12 | 2018 | 44 | |
| 13 | 2016 | 41 | |
| 14 | 2018 | 39 | |
| 15 | 2017 | 38 | |
| 16 | 2020 | 38 | |
| 17 | 2016 | 37 | |
| 18 | 2014 | 36 | |
| 19 | 2011 | 35 | |
| 20 | 2019 | 33 |
About Chia‐Chi Lin
Chia‐Chi Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 116 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (37 papers), Cancer Immunotherapy and Biomarkers (23 papers), Lung Cancer Research Studies (16 papers), Esophageal Cancer Research and Treatment (15 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer Genomics and Diagnostics (13 papers), Cancer therapeutics and mechanisms (10 papers) and Bladder and Urothelial Cancer Treatments (8 papers). The work is most often cited by research in Oncology (968 citations), Pulmonary and Respiratory Medicine (1.0k citations), Cancer Research (236 citations), Immunology (238 citations) and Hepatology (65 citations). Chia‐Chi Lin has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include James Chih‐Hsin Yang, Jih‐Hsiang Lee, Bin-Chi Liao, Chih‐Hung Hsu, Jin‐Yuan Shih, Ann‐Lii Cheng, Chao‐Chi Ho, Chong‐Jen Yu, Todd M. Bauer and Benjamin Solomon. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal of Thoracic Oncology, Investigational New Drugs and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.